128 results
Page 4 of 7
S-4
EX-10.43
k2hko3 kl
7 Feb 20
Registration of securities issued in business combination transactions
5:07pm
S-4
EX-10.29
xdupc
7 Feb 20
Registration of securities issued in business combination transactions
5:07pm
S-4
EX-10.55
cq7z a1g261
7 Feb 20
Registration of securities issued in business combination transactions
5:07pm
S-4
EX-10.16
0tjt2ahk6l0bnj
7 Feb 20
Registration of securities issued in business combination transactions
5:07pm
S-4
EX-10.45
zj19w8lz 5k53pkvo
7 Feb 20
Registration of securities issued in business combination transactions
5:07pm
S-4
EX-10.58
2smwob9rgopgwr3
7 Feb 20
Registration of securities issued in business combination transactions
5:07pm
S-4
EX-10.62
156l84fs
7 Feb 20
Registration of securities issued in business combination transactions
5:07pm
8-K
EX-10.1
xmpow2x
4 Oct 19
Entry into a Material Definitive Agreement
4:06pm
8-K
EX-10.2
simwfgelnb
1 Aug 19
Departure of Directors or Certain Officers
7:00am
8-K
EX-10.1
ddrmzd91
1 Aug 19
Departure of Directors or Certain Officers
7:00am
8-K
EX-10.2
4ignp
1 Sep 17
Conatus Pharmaceuticals Appoints Keith W. Marshall as Executive Vice President, Chief Operating Officer and Chief Financial Officer
12:00am
8-K
EX-10.1
3gk9d 29f
1 Sep 17
Conatus Pharmaceuticals Appoints Keith W. Marshall as Executive Vice President, Chief Operating Officer and Chief Financial Officer
12:00am
8-K
EX-10.1
hnstjg
11 May 17
Conatus Announces Proposed Public Offering of Common Stock
12:00am